Kynexis Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $112M

  • Investors
  • 4

Kynexis General Information

Description

Developer of a precision medicine intended for the treatment of cognitive impairment associated with schizophrenia. The company offers a human biology-based approach for its target rationale, a causal biomarker approach to establish its mechanism of action in clinical development, and a human genetics approach to identify responder subpopulations, enabling patients suffering from schizophrenia to restore their brain function.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kynexis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 19-Aug-2026 $112M Completed Startup
To view Kynexis’s complete valuation and funding history, request access »

Kynexis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a precision medicine intended for the treatment of cognitive impairment associated with schizophrenia. The
Drug Discovery
Naarden, Netherlands
20 As of 2026

London, United Kingdom
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kynexis Competitors (26)

One of Kynexis’s 26 competitors is MiNA Therapeutics, a Venture Capital-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MiNA Therapeutics Venture Capital-Backed London, United Kingdom
Bridge Medicines Venture Capital-Backed New York, NY
EyePoint Corporation Watertown, MA
Kinomica Venture Capital-Backed Macclesfield, United Kingdom
Stemina Biomarker Discovery Venture Capital-Backed Madison, WI
You’re viewing 5 of 26 competitors. Get the full list »

Kynexis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kynexis Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Forbion Venture Capital Minority
Novartis Venture Fund Corporate Venture Capital Minority
Sunstone Life Science Ventures Venture Capital Minority
Ysios Capital Venture Capital Minority
To view Kynexis’s complete investors history, request access »

Kynexis FAQs

  • When was Kynexis founded?

    Kynexis was founded in 2023.

  • Where is Kynexis headquartered?

    Kynexis is headquartered in Naarden, Netherlands.

  • What is the size of Kynexis?

    Kynexis has 20 total employees.

  • What industry is Kynexis in?

    Kynexis’s primary industry is Drug Discovery.

  • Is Kynexis a private or public company?

    Kynexis is a Private company.

  • What is Kynexis’s current revenue?

    The current revenue for Kynexis is .

  • How much funding has Kynexis raised over time?

    Kynexis has raised $112M.

  • Who are Kynexis’s investors?

    Forbion, Novartis Venture Fund, Sunstone Life Science Ventures, and Ysios Capital have invested in Kynexis.

  • Who are Kynexis’s competitors?

    MiNA Therapeutics, Bridge Medicines, EyePoint, Kinomica, and Stemina Biomarker Discovery are some of the 26 competitors of Kynexis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process